Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
Science Advances|April 29, 2026
PARP4 ADP-ribosylates PIDD1 to complete a phospho/SUMO/PAR-ylation cascade that orchestrates PIDDosome assemblyRicha B Shah, Yuanyuan Li, Ashley Person, et al.Journal of Extracellular Vesicles|April 30, 2025
1,4-Dioxane Induces Epithelial-Mesenchymal Transition and Carcinogenesis in an Nrf2-Dependent MannerZiwei Wang, Chitra Thakur, Zhuoyue Bi, et al.Biochemical Pharmacology|October 18, 2003
Identification and characterization of mechanistically distinct inducers of gamma-globin transcriptionJohn D Haley, David E Smith, Janine Schwedes, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 14, 2021
The doxorubicin-induced cell motility network is under the control of the ceramide-activated protein phosphatase 1 alphaDaniel Canals, Silvia Salamone, Bruno Jaime Santacreu, et al.Clinical & Experimental Metastasis|February 1, 2008
Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitionsSharon Barr, Stuart Thomson, Elizabeth Buck, et al.SLAS Discovery : Advancing Life Sciences R & D|August 1, 2020
Identification of Small-Molecule Inhibitors of Neutral Ceramidase (nCDase) via Target-Based High-Throughput ScreeningYuka Otsuka, Michael V Airola, Yong-Mi Choi, et al.Cancer Research|October 17, 2008
Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptorsElizabeth Buck, Alexandra Eyzaguirre, Maryland Rosenfeld-Franklin, et al.ACS Infectious Diseases|August 6, 2025
Identifying Modulators of the Post-Antibiotic EffectAlexa L Gilberti, Megan M Tu, Kenneth Rachwalski, et al.Bioorganic Chemistry|August 2, 2023
Neutral ceramidase-active site inhibitor chemotypes and binding modesNicolas Coant, John D Bickel, Ronald Rahaim, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 16, 2018
De novo lipogenesis represents a therapeutic target in mutant Kras non-small cell lung cancerAnju Singh, Christian Ruiz, Kavita Bhalla, et al.Pageof 6